420 With CNW - Scientific Review Finds Marijuana Lowers Chronic Nerve Pain

10/31/2024 11:05:00 PM

(MENAFN- Investor Brand Network) A recent review highlights the
promising effects of cannabinoids , a compound in cannabis, in managing persistent nerve pain. According to the research, cannabinoids may offer substantial pain relief with few or no side effects, suggesting a valuable alternative to conventional pain medications for patients dealing with persistent nerve pain.

Published in the Cureus journal, the review underscores the positive impact of cannabinoids on pain control, noting their benefits as a more natural...

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text
CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published:
/Disclaimer

CannabisNewsWire
Denver, CO

303.498.7722 Office
[email protected]

CannabisNewsWire is powered by
IBN

MENAFN31102024000224011066ID1108840277

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.